Prednisone

Prednisone Reactions 1680, p282 - 2 Dec 2017 Congenital cytomegalovirus infection following in utero exposure and Guillain Barre syndrome with cytomegalovirus infection: 2 case reports A 30-year-old woman developed Guillain Barre syndrome (GBS) and cytomegalovirus (CMV) infection during pregnancy following treatment with prednisone. Subsequently, her foetus [sex not stated] developed fatal congenital CMV infection following in utero exposure to prednisone [route and duration of treatment to reaction onsets not stated]. The woman was admitted to hospital with the complaints of paraesthesia, numbness and progressive symmetric ascending weakness in the legs associated with difficulty in walking. She th had undergone in-vitro fertilisation and was in the 10 week of th pregnancy and 12 week of amenorrhoea. Her history included a spontaneous abortion. She also had weakly positive antinuclear antibodies. Consequently, she received th prednisone 0.3 mg/kg/day till the 12 week of amenorrhoea. Ten days before the onset of neurological symptoms, she developed flu-like infection. Deep tendon reflexes were absent in the lower and upper limbs and were revealed by clinical examination. Elevated protein concentration was observed in the cerebrospinal fluid (CSF) specimen. Based on the CSF examination, electrophysiological studies and clinical signs, a diagnosis of GBS in the acute inflammatory demyelinating polyradiculoneuropathy was made. She received high dose standard immune globulin[Ivig; Tegeline] on day 2 of the hospitalisation. She was transferred to the ICU. She received parenteral nutrition due to difficulty in swallowing. She also developed left-sided palsy on day 5. Prophylactic anti- coagulation was administered. She was transferred to the neurology department, and her condition improved. However, difficulty in walking still persisted at the time of discharge. Presence of anti-CMV-specific IgM antibodies combined with anti-CMV-specific IgG antibodies was revealed by serological tests performed on day 2 of hospitalisation. Low-avidity anti- CMV IgG antibodies were also detected. CMV primary infection at an early stage of pregnancy was diagnosed. PCR was negative in the CSF, but positive in the whole blood. The foetus had a high-risk of CMV infection due to mother- foetus transmission. Consequently, amniocentesis was planned at 21 weeks of amenorrhoea for virological analysis and monthly ultrasound (US) monitoring was initiated. Fluctuating values of whole blood CMV DNA load were observed from the virological monitoring. US monitoring at 21 weeks of amenorrhoea revealed placentomegaly with diffuse calcification, hyperechogenic bowel and retarded intrauterine growth of less than 3%. Oligohydramnios was noted and hence amniocentesis could not be performed. th Intrauterine foetal death was diagnosed in the 25 week of amenorrhoea and delivery was prompted. Amniotic fluid could not be collected. Chronic villitis was observed from the pathological findings of the placenta. Immuno-histochemical staining revealed CMV-positive placental cell nuclei. PCR for CMV was positive in the placenta with a high viral load. These findings were consistent with congenital CMV infection. Author comment: "We describe an unusual case of GBS after CMV primary infection in a pregnant woman." "[W]e do not know whether the initial moderate-dose corticosteroid therapy received before hospitalization could have interfered with the patient’s cellular immune response." ""[I]n utero fetal death caused by CMV congenital infection unfortunately occurred." Lupo J, et al. Guillain-Barre syndrome and cytomegalovirus infection during pregnancy. Journal of Clinical Virology 79: 74-76, Jun 2016. Available from: URL: https://doi.org/10.1016/j.jcv.2016.04.010 - France 803285546 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Prednisone

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/prednisone-tiXfjqYe4S
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39213-6
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p282 - 2 Dec 2017 Congenital cytomegalovirus infection following in utero exposure and Guillain Barre syndrome with cytomegalovirus infection: 2 case reports A 30-year-old woman developed Guillain Barre syndrome (GBS) and cytomegalovirus (CMV) infection during pregnancy following treatment with prednisone. Subsequently, her foetus [sex not stated] developed fatal congenital CMV infection following in utero exposure to prednisone [route and duration of treatment to reaction onsets not stated]. The woman was admitted to hospital with the complaints of paraesthesia, numbness and progressive symmetric ascending weakness in the legs associated with difficulty in walking. She th had undergone in-vitro fertilisation and was in the 10 week of th pregnancy and 12 week of amenorrhoea. Her history included a spontaneous abortion. She also had weakly positive antinuclear antibodies. Consequently, she received th prednisone 0.3 mg/kg/day till the 12 week of amenorrhoea. Ten days before the onset of neurological symptoms, she developed flu-like infection. Deep tendon reflexes were absent in the lower and upper limbs and were revealed by clinical examination. Elevated protein concentration was observed in the cerebrospinal fluid (CSF) specimen. Based on the CSF examination, electrophysiological studies and clinical signs, a diagnosis of GBS in the acute inflammatory demyelinating polyradiculoneuropathy was made. She received high dose standard immune globulin[Ivig; Tegeline] on day 2 of the hospitalisation. She was transferred to the ICU. She received parenteral nutrition due to difficulty in swallowing. She also developed left-sided palsy on day 5. Prophylactic anti- coagulation was administered. She was transferred to the neurology department, and her condition improved. However, difficulty in walking still persisted at the time of discharge. Presence of anti-CMV-specific IgM antibodies combined with anti-CMV-specific IgG antibodies was revealed by serological tests performed on day 2 of hospitalisation. Low-avidity anti- CMV IgG antibodies were also detected. CMV primary infection at an early stage of pregnancy was diagnosed. PCR was negative in the CSF, but positive in the whole blood. The foetus had a high-risk of CMV infection due to mother- foetus transmission. Consequently, amniocentesis was planned at 21 weeks of amenorrhoea for virological analysis and monthly ultrasound (US) monitoring was initiated. Fluctuating values of whole blood CMV DNA load were observed from the virological monitoring. US monitoring at 21 weeks of amenorrhoea revealed placentomegaly with diffuse calcification, hyperechogenic bowel and retarded intrauterine growth of less than 3%. Oligohydramnios was noted and hence amniocentesis could not be performed. th Intrauterine foetal death was diagnosed in the 25 week of amenorrhoea and delivery was prompted. Amniotic fluid could not be collected. Chronic villitis was observed from the pathological findings of the placenta. Immuno-histochemical staining revealed CMV-positive placental cell nuclei. PCR for CMV was positive in the placenta with a high viral load. These findings were consistent with congenital CMV infection. Author comment: "We describe an unusual case of GBS after CMV primary infection in a pregnant woman." "[W]e do not know whether the initial moderate-dose corticosteroid therapy received before hospitalization could have interfered with the patient’s cellular immune response." ""[I]n utero fetal death caused by CMV congenital infection unfortunately occurred." Lupo J, et al. Guillain-Barre syndrome and cytomegalovirus infection during pregnancy. Journal of Clinical Virology 79: 74-76, Jun 2016. Available from: URL: https://doi.org/10.1016/j.jcv.2016.04.010 - France 803285546 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off